However, recent findings suggest that CFTR modulators, such as Ivacaftor (a CFTR enhancer), show promise in treating acquired CFTR dysfunction in COPD patients, particularly those with chronic bronchitis [41,42]. This evidence concerns the gene CFTR and chronic bronchitis.